Skip to the main content

Professional paper

https://doi.org/10.15836/ccar.2015.157

The Role of Sartans in Cardiovascular Prevention

Ljiljana Banfić ; University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia


Full text: croatian pdf 333 Kb

page 157-161

downloads: 363

cite

Full text: english pdf 333 Kb

page 157-161

downloads: 456

cite


Abstract

The application of angiotensin receptor blockers (AT1) in cardiovascular prevention is based on the treatment of arterial hypertension. Telmisartan, a medication from the sartan group, has not only an antihypertensive effect but proven pleiotropic, metabolic, biohumoral, antiproliferative, and vascular effects – the basic processes of vascular aging as well as the progression of atherosclerosis, a disease with a high mortality that requires early risk recognition and comprehensive primary and secondary cardiovascular prevention. Based on scientific evidence, telmisartan has been proven to provide a well tolerated antihypertensive effect over 24 hours, and is indicated in the prevention of cardiovascular diseases.

Keywords

angiotensin receptor blockers; cardiovascular prevention; telmisartan

Hrčak ID:

141138

URI

https://hrcak.srce.hr/141138

Publication date:

5.7.2015.

Article data in other languages: croatian

Visits: 1.484 *